Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
Journal of Hepatology
|
March 1, 1996
Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma
J P Bronowicki, K Boudjema, L Chone, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
January 1, 1997
Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma
D Jaeck, J P Bronowicki, K Boudejma, et al.
Leukemia
|
November 20, 2009
Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity
B Gerby, F Armstrong, P B de la Grange, et al.
Oncogene
|
January 29, 2014
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia
E Pasmant, B Gilbert-Dussardier, A Petit, et al.
Leukemia
|
February 16, 2016
DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice
L Scourzic, L Couronné, M T Pedersen, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
Journal of Hepatology
|
March 1, 1996
Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma
J P Bronowicki, K Boudjema, L Chone, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|
January 1, 1997
Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma
D Jaeck, J P Bronowicki, K Boudejma, et al.
Leukemia
|
November 20, 2009
Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity
B Gerby, F Armstrong, P B de la Grange, et al.
Oncogene
|
January 29, 2014
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia
E Pasmant, B Gilbert-Dussardier, A Petit, et al.
Leukemia
|
February 16, 2016
DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice
L Scourzic, L Couronné, M T Pedersen, et al.
Page
of 6